中文

百诚医药 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-24
ItemAmountY/Y
Revenue¥0.16B+24.6%
Gross profit¥0.08B
Operating income¥0.01B
Net income¥0.01B
Gross margin50.5%Net margin 8.0%
Revenue Q/Q-4.5%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.08B49.5%
R&D¥0.03B20.9%
SG&A¥0.03B19.2%
Tax & other¥-0.00B-0.4%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

天益医疗金埔园林雅创电子风光股份明月镜片兆讯传媒何氏眼科鸿铭股份骏成科技瑜欣电子洁雅股份军信股份

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies